SEC Form 4 · accession 0001225208-16-031947
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin J. Ballinger
Officer — SVP & Pres, Interven Cardio
Period of report
Apr 27, 2016
Accepted (ET)
Apr 28, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 27, 2016 | M | 36,630 | $7.71 | A | 83,600 | D | |
| Common StockF2 | Apr 27, 2016 | M | 35,000 | $8.30 | A | 118,600 | D | |
| Common StockF2 | Apr 27, 2016 | M | 23,077 | $7.41 | A | 141,677 | D | |
| Common StockF2 | Apr 27, 2016 | M | 17,100 | $15.91 | A | 158,777 | D | |
| Common StockF3,F2 | Apr 27, 2016 | S | 111,807 | $21.6156 | D | 46,970 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $7.41 | Apr 27, 2016 | M | 23,077 | D | — | Feb 16, 2020 | Common Stock | 23,077 | 0 | D |
| Stock Option (Right to Buy)F5 | $8.30 | Apr 27, 2016 | M | 35,000 | D | — | Feb 24, 2019 | Common Stock | 35,000 | 0 | D |
| Stock Option (Right to Buy)F6 | $7.71 | Apr 27, 2016 | M | 36,630 | D | — | Oct 28, 2018 | Common Stock | 36,630 | 0 | D |
| Stock Option (Right to Buy)F7 | $15.91 | Apr 27, 2016 | M | 17,100 | D | — | Oct 31, 2016 | Common Stock | 17,100 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Represents the weighted average sale price. These shares were sold in multiple transactions at $21.40 and $22.00. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4Grant to the reporting person of an option to purchase a specified number of shares of common stock on February 16, 2010. This option is fully vested.
- F5Grant to the reporting person of an option to purchase a specified number of shares of common stock on February 24, 2009. This option is fully vested.
- F6Grant to the reporting person of an option to purchase a specified number of shares of common stock on October 28, 2008. This option is fully vested.
- F7Grant to the reporting person of an option to purchase a specified number of shares of common stock on October 31, 2006. This option is fully vested